Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ripping The Bandage Off: GSK Resolves Suits On Many Products For $2.3 Bil.

Jul 19 2010

• By The Pink Sheet

Related Content

FDA Consent Decree’s Impact Is Limited, GSK Says

Apr 28 2005

FDA Seizure Of Paxil CR, Avandamet Follows GSK's Failure To Recall All Lots

Mar 04 2005

Grassley And Baucus Turn Up Heat On GSK With Attack On Avandia Data Handling

Jul 13 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window